Abstract

Complete donor T‐cell engraftment 30 days after allogeneic transplantation predicts molecular remission in high‐risk chronic lymphocytic leukaemia

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Guideline for the treatment of chronic lymphocytic leukaemia
Nilima Parry‐Jones ... John C Riches
British Journal of Haematology | VOL. 197
Nilima Parry‐Jones, et. al.Nilima Parry‐Jones ... John C Riches
21 Mar 2022
Surprise! HSC Are Aberrant in Chronic Lymphocytic Leukemia
Ravindra Majeti ... Ash A Alizadeh
Cancer Cell | VOL. 20
Ravindra Majeti, et. al.Ravindra Majeti ... Ash A Alizadeh
01 Aug 2011
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
C Buske ... M Hallek
Annals of Oncology | VOL. 26
C Buske, et. al.C Buske ... M Hallek
01 Sep 2015
Complete Donor Chimerism Predicts Molecular Remission in High Risk CLL Following Nonmyeloablative Transplantation.
David Miklos ... Renee Letzinger
Blood | VOL. 112
David Miklos, et. al.David Miklos ... Renee Letzinger
16 Nov 2008
View more papers

More From: British Journal of Haematology

Paper Title
Journal
Date
Author
Tyrosine kinase inhibitor maintenance following chimeric antigen receptor T-cell therapy in Philadelphia chromosome-positive acute lymphoblastic leukaemia.
Tamer Othman ... Ibrahim Aldoss
British journal of haematology | VOL. -
Tamer Othman, et. al.Tamer Othman ... Ibrahim Aldoss
29 May 2024
Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I-BFM Study Group.
Herbert Pichler ... Adriana Balduzzi
British journal of haematology | VOL. -
Herbert Pichler, et. al.Herbert Pichler ... Adriana Balduzzi
27 May 2024
Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre-autologous stem cell transplant in relapsed/refractory diffuse large B-cell lymphoma-outcome of rituximab-dose-intensive cyclophosphamide, etoposide, cisplatin (R-DICEP) versus R-GDP.
Douglas A Stewart ... Michael Crump
British journal of haematology | VOL. -
Douglas A Stewart, et. al.Douglas A Stewart ... Michael Crump
27 May 2024
RUNX1::ETO and CBFβ::MYH11 converge on aberrant activation of BCAT1 to confer a therapeutic vulnerability in core-binding factor-acute myeloid leukaemia.
Siyang Wang ... Kankan Wang
British journal of haematology | VOL. -
Siyang Wang, et. al.Siyang Wang ... Kankan Wang
27 May 2024
View more papers